Trial data show FX45 may help improve heart function in people with pulmonary hypertension and heart failure with reduced ejection fraction.
Angiotensin receptor-neprilysin inhibitors (ARNIs) represent a significant advancement in heart failure therapy, combining an ...
An initiative launched by the American Heart Association in September aims to improve in-hospital patient care for patients with HFpEF and HFmrEF.
SGLT2 inhibitors represent one of the most remarkable therapeutic developments in heart failure care, transitioning from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback